BBLG Insider Trading Activity and SEC Form 4 Filings
BBLG insider trading summary
No open-market insider purchases or sales of Bone Biologics Corp (BBLG) have been reported on SEC Form 4 in the past 12 months.
Latest BBLG insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 13, 2023 | Deina H Walsh | Chief Financial Officer | Buy | $5K (8,000 @ $0.64) |
| Sep 11, 2023 | Jeff Frelick | Chief Executive Officer | Buy | $7K (9,500 @ $0.69) |
| Sep 6, 2023 | Deina H Walsh | Chief Financial Officer | Buy | $5K (6,700 @ $0.71) |
| Sep 6, 2023 | Deina H Walsh | Chief Financial Officer | Buy | $210 (300 @ $0.70) |
| Aug 31, 2023 | Jeff Frelick | Chief Executive Officer | Buy | $5K (7,600 @ $0.66) |
| Jan 2, 2020 | Bret Hankey | Director | Buy | $195K (195,000 @ $1.00) |
| Jan 2, 2020 | Hankey Capital, LLC | 10% Owner | Buy | $195K (195,000 @ $1.00) |
| Jan 2, 2020 | Don Hankey | Chairman of the Board | Buy | $195K (195,000 @ $1.00) |
| Jan 2, 2020 | Don Hankey Trust | Insider | Buy | $195K (195,000 @ $1.00) |
| Aug 6, 2019 | Don Hankey Trust | Insider | Buy | $0 (553,191 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.